Spots Global Cancer Trial Database for amg 162 180 mg (sc) q 12 weeks
Every month we try and update this database with for amg 162 180 mg (sc) q 12 weeks cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Study of AMG 162 in Subjects With Advanced Cancer Currently Being Treated With Intravenous (IV) Bisphosphonates | NCT00104650 | Bone Metastases... Bone Metastases... Bone Metastases... | AMG 162 180 mg ... IV Bisphosphona... AMG 162- 180 mg... | 18 Years - | Amgen | |
Study of AMG 162 in Subjects With Advanced Cancer Currently Being Treated With Intravenous (IV) Bisphosphonates | NCT00104650 | Bone Metastases... Bone Metastases... Bone Metastases... | AMG 162 180 mg ... IV Bisphosphona... AMG 162- 180 mg... | 18 Years - | Amgen |